New treatment tested to tame dust mite allergies and asthma
NCT ID NCT05720325
Summary
This study is testing whether the medication dupilumab can reduce allergy and asthma symptoms triggered by house dust mites. Researchers will expose 88 adults with dust mite allergies to controlled amounts of allergens in a special chamber, then give them either dupilumab or a placebo for 18 weeks. The goal is to see if the medication helps control symptoms like sneezing, congestion, wheezing, and coughing when people encounter dust mites.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA, ALLERGIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biogenics Research Chamber
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas Health Science Center at San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.